CSI Market
Sign In | Register

Thorne Healthtech Inc (THRN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access THRN Annual Cash Flow →
This cash flow overview for Thorne Healthtech Inc spans from Jun 30 2022 to Jun 30 2023, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2023)
6 Months 		(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Operating Activities
Income3.80
Depreciation & amortization3.25
Amortization of Other Assets0.09
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-13.24
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation6.62
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.36
Cost Of Goods And Services Sold Depreciation And Amortization-
Noncash Lease Expense1.72
Loss On Drawbridge Transaction-
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Non Cash Interest Expense-
Change In Inventory And Receivable Reserves-
Provision For Losses On Inventories0.27
Loss From Equity Interests In Unconsolidated Affiliate-0.11
Cumulative Effect Changes In Accounting Principle-
Write Off Of Related Party Receivable0.15
Increase Decrease In Operating Lease Liabilities0.22
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-9.06
Accounts Payable18.51
Increase (Decrease) in Other Accrued Liabilities1.16
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-3.39
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.07
Discontinued operations0.00
Net Cash flow from Operating Activities9.29
Investing Activities
Capital Expenditures-21.42
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Investment In Unconsolidated Subsidiaries-
Acquisition Of Nutrativa Net Of Cash Acquired-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Interest in Joint Venture0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-4.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-25.42
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.56
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.16
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1.23
Repayments Of Related Party Short Term Debt-
Proceeds From Issuance Of Long Term Debts-
Repayments Of Long Term Debts-
Proceeds From Issuance Of Ownership Interest In Consolidated Subsidiary-
Payment Of Deferred Offering Costs-
Payment Of Notes Payable Equipment Financing-0.34
Payments On Notes Payable-0.70
Finance Lease Principal Payments-0.89
Payments Of Revolving Line Of Credit-25.00
Investment From Minority Partner In Joint Venture-
Shares Repurchased For Tax Withholdings On Vesting Of Restricted Stock Units-
Proceeds From Revolving Line Of Credit35.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.56
Effect of exchange rate on cash flow-0.06
Discontinued operations0.00
Free Cash Flow-12.14
Total Cash Flow-8.63
4 historic quarters locked

Sign in to unlock the full Thorne Healthtech Inc cash flow history.

Sign In Create Free Account

About Thorne Healthtech Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-040161

Figures are derived from filed reports and may be restated. Historical data is subject to revision.